Acquired
Novo Nordisk (Ozempic)
David Rosenthal
But investors are just mad for biotech companies. So when Novo announces that they're going to be first to market with human insulin... And like, yeah, yeah, just ignore that it's actually pig insulin that we're modifying. They use the hype on the back of that to do a US IPO with Goldman Sachs and raise $100 million. When your currency is expensive, sell it. right?
0
💬
0
Comments
Log in to comment.
There are no comments yet.